Imperial College London
Alternate

Dr Tini Garske

Faculty of Medicine, School of Public Health

Senior Lecturer
 
 
 
//

Contact

 

t.garske Website

 
 
//

Location

 

410School of Public HealthWhite City Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Ozawa:2017:10.2471/BLT.16.178475,
author = {Ozawa, S and Clark, S and Portnoy, A and Grewal, S and Stack, ML and Sinha, A and Mirelman, A and Franklin, H and Friberg, IK and Tam, Y and Walker, N and Clark, A and Ferrari, M and Suraratdecha, C and Sweet, S and Goldie, SJ and Garske, T and Li, M and Hansen, PM and Johnson, HL and Walker, D},
doi = {10.2471/BLT.16.178475},
journal = {Bulletin of the World Health Organization},
pages = {629--638},
title = {Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001-2020},
url = {http://dx.doi.org/10.2471/BLT.16.178475},
volume = {95},
year = {2017}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Objective To estimate the economic impact likely to be achieved by efforts to vaccinate against 10 vaccine-preventable diseases between 2001 and 2020 in 73 low- and middle-income countries largely supported by Gavi, the Vaccine Alliance.Methods  We  used  health  impact  models  to  estimate  the  economic  impact  of  achieving  forecasted  coverages  for  vaccination  against  Haemophilus  influenzae  type  b,  hepatitis  B,  human  papillomavirus,  Japanese  encephalitis,  measles,  Neisseria  meningitidis  serogroup  A,  rotavirus, rubella, Streptococcus pneumoniae and yellow fever. In comparison with no vaccination, we modelled the costs – expressed in 2010 United States dollars (US$) – of averted treatment, transportation costs, productivity losses of caregivers and productivity losses due to disability and death. We used the value-of-a-life-year method to estimate the broader economic and social value of living longer, in better health, as a result of immunization.Findings We estimated that, in the 73 countries, vaccinations given between 2001 and 2020 will avert over 20 million deaths and save US$ 350 billion in cost of illness. The deaths and disability prevented by vaccinations given during the two decades will result in estimated lifelong productivity gains totalling US$ 330 billion and US$ 9 billion, respectively. Over the lifetimes of the vaccinated cohorts, the same vaccinations will save an estimated US$ 5 billion in treatment costs. The broader economic and social value of these vaccinations is estimated at US$ 820 billion.Conclusion By preventing significant costs and potentially increasing economic productivity among some of the world’s poorest countries, the impact of immunization goes well beyond health.
AU  - Ozawa,S
AU  - Clark,S
AU  - Portnoy,A
AU  - Grewal,S
AU  - Stack,ML
AU  - Sinha,A
AU  - Mirelman,A
AU  - Franklin,H
AU  - Friberg,IK
AU  - Tam,Y
AU  - Walker,N
AU  - Clark,A
AU  - Ferrari,M
AU  - Suraratdecha,C
AU  - Sweet,S
AU  - Goldie,SJ
AU  - Garske,T
AU  - Li,M
AU  - Hansen,PM
AU  - Johnson,HL
AU  - Walker,D
DO  - 10.2471/BLT.16.178475
EP  - 638
PY  - 2017///
SN  - 0042-9686
SP  - 629
TI  - Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001-2020
T2  - Bulletin of the World Health Organization
UR  - http://dx.doi.org/10.2471/BLT.16.178475
UR  - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000409463100010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR  - http://hdl.handle.net/10044/1/54302
VL  - 95
ER  -
Download